HCA Healthcare CEO Reports 6% Drop in Elective Surgical Volume Amid ACA Exchange Coverage Losses

HCA Healthcare Chief Executive Officer Sam Hazen disclosed at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, that the company experienced a 6 percent decline in elective surgical volumes during the first half of 2026. This was approximately three times the rate of decline seen in the first half of 2025. The downturn was attributed primarily to patients losing coverage through Affordable Care Act exchanges and becoming uninsured, coupled with cost-sensitive individuals delaying procedures and early impacts from the Centers for Medicare & Medicaid Services’ phase-out of the inpatient-only list. Hazen cautioned that the company does not expect a meaningful rebound in elective surgeries until the fourth quarter, when patients typically resume deferred care after meeting annual deductibles.

This development is consequential for HCA’s near-term volume and revenue forecasts. A steeper-than-expected drop in surgical procedures may pressure margins and operational performance, particularly if delayed volume fails to return as anticipated. Medically elective surgeries often contribute materially to hospital revenue and profitability, meaning sustained weakness could weigh on upcoming financial results.

While no direct correlation between this volume decline and HCA’s stock movements has been reported, investors will likely monitor the company’s upcoming earnings report and guidance for further clarity on how surgical volume trends and insurance coverage gaps may impact second-half performance.

Looking ahead, stakeholders should track whether the anticipated rebound in elective surgical volumes materializes in the fourth quarter and how shifts in insurer coverage—particularly relating to ACA exchange policies—continue to shape payer mix and reimbursement dynamics.